Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Trelstar Generic Name & Formulations
Legal Class
Rx
General Description
Triptorelin pamoate 3.75mg, 11.25mg, 22.5mg; lyophilized microgranules for IM inj after reconstitution; contains mannitol.
Pharmacological Class
GnRH analogue.
How Supplied
MixJect system—1 (vial + vial adapter + prefilled syringe)
Manufacturer
Mechanism of Action
Triptorelin is a synthetic decapeptide agonist analog of gonadotropin releasing hormone (GnRH). In animal studies, triptorelin pamoate was found to have 13‑fold higher luteinizing hormone-releasing activity and 21-fold higher follicle-stimulating hormone-releasing activity compared to the native GnRH.
Trelstar Indications
Indications
Palliative treatment of advanced prostate cancer.
Trelstar Dosage and Administration
Adult
Give by IM inj in buttock. 3.75mg every 4 weeks, or 11.25mg every 12 weeks, or 22.5mg every 24 weeks.
Children
Not established.
Trelstar Contraindications
Not Applicable
Trelstar Boxed Warnings
Not Applicable
Trelstar Warnings/Precautions
Warnings/Precautions
Not for use in women. Must administer under physician supervision. Discontinue if hypersensitivity occurs. Initial transient increase in serum testosterone may result in worsening of signs/symptoms including bone pain, neuropathy, hematuria, or urethral/bladder obstruction. Spinal cord compression. Renal or hepatic impairment. Metastatic vertebral lesions. Upper or lower urinary tract obstruction. May prolong QT/QTc interval in patients with congenital long QT syndrome, CHF, frequent electrolyte abnormalities. Correct any electrolyte abnormalities; monitor ECGs and electrolytes periodically. Increased risk of diabetes, MI, sudden cardiac death, stroke; monitor blood glucose and/or HbA1c, and for signs/symptoms of cardiovascular disease. Measure serum testosterone periodically. Embryo-fetal toxicity. Pregnancy. Nursing mothers: not recommended.
Trelstar Pharmacokinetics
Elimination
Renal, fecal. Half-life: 3 hours (terminal).
Trelstar Interactions
Interactions
Concomitant hyperprolactinemic drugs: not recommended. Avoid concomitant drugs that are known to prolong the QT interval. May interfere with pituitary gonadotropic function tests.
Trelstar Adverse Reactions
Adverse Reactions
Inj site reactions, hot flushes, skeletal pain, impotence, headache, leg edema/pain, erectile dysfunction, testicular atrophy; hyperglycemia.
Trelstar Clinical Trials
See Literature
Trelstar Note
Not Applicable
Trelstar Patient Counseling
See Literature
